Drug Trial Radar · NCT03700749
FALCON Trial Testing Measures to Reduce Surgical Site Infection
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,788
Actual
Start
Nov 29, 2018
Primary completion
Sep 7, 2020
Study completion Oct 31, 2020
Sponsor
- Lead sponsor
- University of BirminghamAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Lagos State University; Kigali University Teaching Hospital; Christian Medical College and Hospital, Ludhiana, India; University of Edinburgh; University of Witwatersrand, South Africa; Abomey Calavi; Hospital Espanol Veracruz; Ministry of Health, Ghana
- First posted
- Oct 9, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
FALCON is a Pragmatic multi-centre trial testing measures to reduce superficial or deep skin infection following abdominal surgery in low and middle income countries. The trial will recruit patients undergoing abdominal surgery. Recruited participants will be randomly assigned to four arms to receive different combinations of skin preparation and sutures for would closure: A. In this arm surgeon will use 2% alcoholic chlorhexidine for skin cleansing and non-coated suture for wound closure; B. In this arm surgeon will use 2% alcoholic chlorhexidine for skin cleansing and triclosan coated suture for wound closure; C. In this arm surgeon will use for operation 10% aqueous povidone-iodine for skin cleansing and non-coated suture for wound closure; D. In this arm surgeon will use 10% aqueous povidone-iodine for skin cleansing and triclosan-coated suture.
Conditions
- Abdominal Surgery
- Surgical Site Infection
Interventions
2% chlorhexidine + non-coated sutureDrug
Interventions: 2% alcoholic chlorhexidine non-coated suture
2% chlorhexidine + coated sutureDrug
Interventions: 2% alcoholic chlorhexidine triclosan coated suture
10%povidone-iodine + non-coated sutureDrug
Interventions: 10% povidone-iodine non-coated suture non-coated suture
10%povidone-iodine + coated sutureDrug
Interventions: 10% povidone-iodine triclosan coated suture
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical site infection (SSI)Time frame: At 30-days post-surgery
Locations
7 sites in 7 countries. Site status is shown where the registry gives one.
University of Abomey Calavi
Cotonou, Benin
Tamale Teaching Hospital, Tamale
Tamale, Ghana
Christian Medical College and Hospital Ludhiana
Ludhiana, India
Hospital Espanol Veracruz
Veracruz, Mexico
Lagos University Teaching Hospital
Lagos, Nigeria
University Teaching Hospital of Kigali (Hub), Kigali
Kigali, Rwanda
University of the Witwatersrand
Johannesburg, South Africa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.